About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, reproducible and disease-relevant protein measurement. This panel delivers simultaneous measurement of 41 key and emerging proteins for neurodegeneration research with absolute quantification and optimized for plasma measurement from as little as 1µL of sample.

The Target 48 Neurodegeneration panel is the latest addition to Olink’s growing portfolio of multiplex disease panels with absolute quantification readouts. Alongside the Olink® Target 48 Cytokine, Olink® Target 48 Immune Surveillance, and the semi-custom Olink® Flex platform, this solution helps create a powerful ecosystem for proteomics research. When combined, these panels allow researchers to seamlessly analyze a larger library of protein biomarkers that can help provide comprehensive insights into neurodegeneration and inflammation in the body.

An early access user, Charlotte Teunissen, professor in neurochemistry at the Department of Laboratory Medicine at Amsterdam University Medical Center, shared, “The Target 48 Neurodegeneration panel is a critical tool that enables the detection and quantification of key and emerging neurodegenerative disease biomarkers from plasma and cerebrospinal fluid samples. By generating quantitative data, it ensures reproducible results across and within longitudinal studies, moving a step forward towards clinical utilization.”

"Neurological diseases are complex, multifactorial and urgently in need of translational insights especially with non-invasive proteomic biomarkers for longitudinal monitoring," said Yan Zhang, President of the Proteomic Sciences business at Thermo Fisher Scientific. “The panel, designed in close collaboration with leading clinical researchers, offers absolute quantification of multiplex key biomarkers to monitor disease progression and therapeutic responses to power precision medicine."

Key benefits of the Olink® Target 48 Neurodegeneration include:

  • Targeted depth: 41 protein biomarkers selected for relevance across Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s disease and other neurodegenerative disorders.
  • Absolute quantification: Ability to quantify key and emerging biomarkers for neurodegeneration research simultaneously in one panel.
  • Minimal sample input: Enables high-throughput studies with precious or biobank samples.
  • Scalability and standardization: Compatible with Thermo Fisher’s global network of Olink-equipped labs for reproducibility across sites, critical for multi-center trials and large consortia.
  • Proven solution: Uses Olink’s gold-standard Proximity Extension Assay (PEA) technology.

The new panel reinforces Thermo Fisher’s commitment to advancing precision medicine and neurology research, joining the company’s broader suite of tools spanning mass spectrometry, cryo-electron microscopy, and multiplex immunoassays. It builds on recent initiatives such as the UK Biobank proteomics program, the Geisinger Health Study with the Regeneron Genetics Center and cross-platform collaborations with leading biopharma companies.

The Olink® Target 48 Neurodegeneration has been developed with the aim of reducing import barriers such as long lead-times for importing into geographies with blood or plasma-derived import licenses. The Olink® Target 48 Neurodegeneration panel is fully compatible with the Olink® Signature Q100 benchtop system, providing a simplified workflow, minimal instrument maintenance and streamlined quality control, enabling laboratories to accelerate their biomarker research.

To learn more about the Olink® Target 48 Neurodegeneration Panel, please visit our website and register for the webinar on September 17, 2025. This panel and a discussion on neurodegenerative disease research will also be featured at the premier global virtual conference Olink Proteomics World on October 8, 2025.

*For research use only. Not for use in diagnostic procedures.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. For more information, please visit www.thermofisher.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.